(Q39867384)

15 September 2017

title

Do phase 1 patients have greater needs for palliative care compared with other cancer patients? (English)

1 reference

15 September 2017

Esmé Finlay

1

1 reference

15 September 2017

Hien L Lu

2

1 reference

15 September 2017

Hope R Henderson

3

1 reference

15 September 2017

Peter J O'Dwyer

4

1 reference

15 September 2017

David J Casarett

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

115

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

446-453

1 reference

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Family perspectives on end-of-life care at the last place of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Improving the Use of Hospice Services in Nursing Homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Does receipt of hospice care in nursing homes improve the management of pain at the end of life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Hospice benefits and phase I cancer trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Hospice patients in clinical cancer treatment trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Must patients with advanced cancer choose between a Phase I trial and hospice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

How should clinicians describe hospice to patients and families?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Making difficult decisions about hospice enrollment: what do patients and families want to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Timing of hospice referral and families' perceptions of services: are earlier hospice referrals better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Ethics of phase 1 oncology studies: reexamining the arguments and data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

How should we design supportive cancer care? The patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Project ENABLE: a palliative care demonstration project for advanced cancer patients in three settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Promoting excellence in end-of-life care: a report on innovative models of palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Does a palliative care clinic have a role in improving end-of-life care? Results of a pilot program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Symptom evaluation in palliative medicine: patient report vs systematic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Symptom burden: multiple symptoms and their impact as patient-reported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Assessment of symptom clusters in people with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

Hospice enrollment and pain assessment and management in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Prognostic factors for survival in patients treated in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Participants in phase 1 oncology research trials: are they vulnerable?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Impact of quality of life on patient expectations regarding phase I clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Simultaneous care: disease treatment and palliative care throughout illness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Project Safe Conduct Integrates Palliative Goals into Comprehensive Cancer Care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

ASCO-ESMO consensus statement on quality cancer care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24025

7 January 2021

Identifiers

DOI

10.1002/CNCR.24025

1 reference

15 September 2017

1 reference